Prevention of Stroke: Carotid Artery Stenting or Endarterectomy?

Original Title: Long-Term Outcome after Carotid Artery Stenting. A Population-Based Matched Cohort Study.

Reference: Stroke. 2016 Jul 12. [Epub ahead of print].

 

Carotid Artery Stenting EndarterectomyIn the prevention of stroke, carotid artery stenting (CAS) is far less invasive than endarterectomy, but its long term outcomes remain unclear.

This large cohort study compared the long term outcomes of CAS vs. endarterectomy.

All patients included in the Swedvasc registry (National Swedish Vascular Registry) treated with CAS between 2005 and 2012 were identified. For every CAS procedure, 2 control endarterectomy procedures were included, matched by:

 

  • sex
  • age
  • year of procedure
  • indication (symptomatic/asymptomatic).

Primary end point was ipsilateral stroke, or death 30 days after procedure.

A total 1157 patients were included (409 CAS and 748 endarterectomy). Median age was 70 and 69% were symptomatic.

Risk factors were similar in both groups and the population was followed up at mean 4.1 years.

Death or stroke rates beyond the 30 days perioperative period occurred in:

  • 95 of 394 CAS patients (25.7%)
  • 120 of 724 endarterectomy patients (18.6%)

[Adjusted risk 1.59; CI 95% 1.15–2.18]

Death rate was:

  • 25.7% with CAS
  • 18.6% with endarterectomy

[HR 1.20; CI 95% 0.84–1.72]

Ipsilateral stroke rate was:

  • 9.4% with CAS
  • 2.9% with endarterectomy

[HR 3.40; CI 95% 1.53–7.53]

Any stroke + death after 30 days was:

  • 34.2% with CAS
  • 23.6% with endarterectomy

[HR 1.49; CI 95% 1.10–2.00]

 

Conclusion

In this cohort study, CAS was associated with a long term increased risk of ipsilateral stroke and death after perioperative period compared to endarterectomy.

 

Editorial Comment

Even though population was matched, some characteristics may be misleading in this kind of studies. Higher mortality in the CAS group cannot be explained by excessive ipsilateral stroke and may be due to higher global risk, which may have favored CAS indication, being less invasive.

 

We value your opinion. You are more than welcome to leave your comments, thoughts, questions or suggestions here below.

More articles by this author

Therapeutic strategies in carotid free-floating thrombus: evidence and controversies

Carotid free-floating thrombus (cFFT) is a rare entity with a high embolic risk, associated with acute neurological events such as stroke or transient ischemic...

ACC 2026 | SirPAD Trial: Sirolimus-coated balloon angioplasty in infrainguinal arterial disease

Paclitaxel-coated balloons have demonstrated improved patency in peripheral arterial disease (PAD), although questions remain regarding safety and applicability across different vascular territories. In this...

ACC 2026 | HI-PEITHO: Catheter-directed strategy (EKOS) in intermediate-risk acute pulmonary embolism

The treatment of intermediate-risk pulmonary embolism (PE) continues to be an area of therapeutic uncertainty. The initial PEITHO study (2014) demonstrated a reduction in...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...

Therapeutic strategies in carotid free-floating thrombus: evidence and controversies

Carotid free-floating thrombus (cFFT) is a rare entity with a high embolic risk, associated with acute neurological events such as stroke or transient ischemic...

The Two Sides of the Coin: What Do CHAMPION-AF and CLOSURE-AF Teach Us About Left Atrial Appendage Closure?

Letter to the editor: Juan Manuel Pérez Asorey Percutaneous left atrial appendage closure (LAAO) is currently going through one of the most interesting stages of...